The placebo response in medicine: minimize, maximize or personalize?

New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov (2013) 1.63

Randomised controlled trial of mesalazine in IBS. Gut (2014) 1.58

Retracted The Effects of Positive or Neutral Communication during Acupuncture for Relaxing Effects: A Sham-Controlled Randomized Trial. Evid Based Complement Alternat Med (2016) 1.39

Socially induced placebo analgesia: a comparison of a pre-recorded versus live face-to-face observation. Eur J Pain (2013) 1.03

Placebo effects in obesity research. Obesity (Silver Spring) (2016) 0.96

Expectations affect psychological and neurophysiological benefits even after a single bout of exercise. J Behav Med (2016) 0.95

Randomised controlled trials may underestimate drug effects: balanced placebo trial design. PLoS One (2014) 0.95

Role of conditioning and verbal suggestion in placebo and nocebo effects on itch. PLoS One (2014) 0.93

Functional network architecture predicts psychologically mediated analgesia related to treatment in chronic knee pain patients. J Neurosci (2014) 0.91

Network modulation following sham surgery in Parkinson's disease. J Clin Invest (2014) 0.89

How can placebo effects best be applied in clinical practice? A narrative review. Psychol Res Behav Manag (2015) 0.89

Relieving pain using dose-extending placebos: a scoping review. Pain (2016) 0.89

Prediction of placebo responses: a systematic review of the literature. Front Psychol (2014) 0.87

Placebo effect in clinical trial design for irritable bowel syndrome. J Neurogastroenterol Motil (2014) 0.87

Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses. PLoS One (2014) 0.85

The placebo effect in allergen-specific immunotherapy trials. Clin Transl Allergy (2013) 0.85

Does the model of additive effect in placebo research still hold true? A narrative review. JRSM Open (2017) 0.84

Cognition and the Placebo Effect--Dissociating Subjective Perception and Actual Performance. PLoS One (2015) 0.84

Placebo eff ects in psychiatry: mediators and moderators. Lancet Psychiatry (2015) 0.83

Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial. BMC Med (2017) 0.82

Placebo use in pain management: The role of medical context, treatment efficacy, and deception in determining placebo acceptability. Pain (2014) 0.82

Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis. PLoS One (2015) 0.82

Cognitive factors mediate placebo responses in patients with house dust mite allergy. PLoS One (2013) 0.82

Randomised placebo-controlled trials of surgery: ethical analysis and guidelines. J Med Ethics (2016) 0.82

Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study. Front Psychiatry (2016) 0.82

Complementary and alternative drug therapy versus science-oriented medicine. Ger Med Sci (2015) 0.80

Expectation modulates the effect of deep brain stimulation on motor and cognitive function in tremor-dominant Parkinson's disease. PLoS One (2013) 0.79

[Psychophysiology of visceral pain]. Schmerz (2014) 0.79

The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis. Trials (2016) 0.78

The role of outcome expectancies for a training program consisting of meditation, breathing exercises, and cold exposure on the response to endotoxin administration: a proof-of-principle study. Clin Rheumatol (2015) 0.78

Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis. Sleep (2015) 0.78

Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicine. Gerontology (2015) 0.77

Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases. Curr Clin Pharmacol (2016) 0.77

Reevaluating the placebo effect in medical practice. Z Psychol (2014) 0.77

Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder. J Psychiatr Res (2016) 0.77

Learning to experience side effects after antidepressant intake - Results from a randomized, controlled, double-blind study. Psychopharmacology (Berl) (2016) 0.76

A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning. Sci Rep (2015) 0.76

The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial. Arthritis (2015) 0.76

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis. J Crohns Colitis (2016) 0.76

Accounting for Behavior in Treatment Effects: New Applications for Blind Trials. PLoS One (2015) 0.76

Patients' Expectations Regarding Medical Treatment: A Critical Review of Concepts and Their Assessment. Front Psychol (2017) 0.75

A virtual experimenter to increase standardization for the investigation of placebo effects. BMC Med Res Methodol (2016) 0.75

Phasic and tonic pain differentially impact the interruptive function of pain. PLoS One (2015) 0.75

The role of expectations in mental disorders and their treatment. World Psychiatry (2017) 0.75

Placebo, nocebo, and neuropathic pain. Pain (2016) 0.75

Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Mol Psychiatry (2016) 0.75

Placebo-induced somatic sensations: a multi-modal study of three different placebo interventions. PLoS One (2015) 0.75

High-dose thiamine improves the symptoms of fibromyalgia. BMJ Case Rep (2013) 0.75

Sympathetic Arousal during a Touch-Based Healing Ritual Predicts Increased Well-Being. Evid Based Complement Alternat Med (2015) 0.75

Reduced Need for Rescue Antiemetics and Improved Capacity to Eat in Patients Receiving Acupuncture Compared to Patients Receiving Sham Acupuncture or Standard Care during Radiotherapy. Evid Based Complement Alternat Med (2017) 0.75

How to study placebo responses in motion sickness with a rotation chair paradigm in healthy participants. J Vis Exp (2014) 0.75

Listen to brain networks responding to placebos! J Physiol (2016) 0.75

Health Complaints Attributed to Dental Amalgam: A Retrospective Survey Exploring Perceived Health Changes Related to Amalgam Removal. Open Dent J (2016) 0.75

Do placebo expectations influence perceived exertion during physical exercise? PLoS One (2017) 0.75

The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials. Clin Rheumatol (2017) 0.75

Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response. Eur Neuropsychopharmacol (2017) 0.75

Physicians' beliefs about placebo and nocebo effects in antidepressants - an online survey among German practitioners. PLoS One (2017) 0.75

Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine. Int J Behav Med (2017) 0.75

The effect of transcranial direct current stimulation on experimentally induced heat pain. Exp Brain Res (2014) 0.75

A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med (2002) 16.75

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med (2008) 11.44

A new design for randomized clinical trials. N Engl J Med (1979) 7.85

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ (2008) 6.97

Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30

Descending control of pain. Prog Neurobiol (2002) 6.20

Nonspecific medication side effects and the nocebo phenomenon. JAMA (2002) 5.79

Biological, clinical, and ethical advances of placebo effects. Lancet (2010) 5.36

Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med (2011) 4.68

The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain (2007) 4.18

The mechanism of placebo analgesia. Lancet (1978) 4.10

Acupuncture for patients with migraine: a randomized controlled trial. JAMA (2005) 3.70

Commercial features of placebo and therapeutic efficacy. JAMA (2008) 3.66

State-dependent opioid control of pain. Nat Rev Neurosci (2004) 3.51

Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry (2008) 3.47

Placebo interventions for all clinical conditions. Cochrane Database Syst Rev (2010) 3.45

Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A (2007) 3.33

The functional neuroanatomy of the placebo effect. Am J Psychiatry (2002) 3.26

Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial. Control Clin Trials (1990) 3.25

Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci (1999) 3.19

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science (2001) 3.18

Active placebos versus antidepressants for depression. Cochrane Database Syst Rev (2004) 3.10

Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 3.03

Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol (2007) 2.99

Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med (2002) 2.97

Individual differences in reward responding explain placebo-induced expectations and effects. Neuron (2007) 2.96

Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network. Neuron (2005) 2.90

The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A (2005) 2.84

Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol (2004) 2.73

Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci (2003) 2.62

Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron (2009) 2.55

The role of learning in nocebo and placebo effects. Pain (2008) 2.53

Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry (2002) 2.39

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol (2008) 2.23

The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med (2011) 2.19

Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov (2011) 2.19

How prior experience shapes placebo analgesia. Pain (2006) 2.15

Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain (2006) 2.09

Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci (2003) 2.08

Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med (2010) 2.05

Behaviorally conditioned immunosuppression. Psychosom Med (1975) 1.97

Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97

Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med (2012) 1.95

The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. PLoS Med (2012) 1.93

Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf (2009) 1.91

The future of primary care: transforming practice. N Engl J Med (2008) 1.91

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88

Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling. Stat Med (2009) 1.87

Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci (2011) 1.84

Direct evidence for spinal cord involvement in placebo analgesia. Science (2009) 1.82

Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81

Recovery expectations and long-term prognosis of patients with coronary heart disease. Arch Intern Med (2011) 1.79

Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom (2009) 1.79

Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. Arch Intern Med (2000) 1.77

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry (2010) 1.76

Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci (2005) 1.73

Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry (2004) 1.72

Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med (2009) 1.68

Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci (2006) 1.67

Frequency and circumstances of placebo use in clinical practice--a systematic review of empirical studies. BMC Med (2010) 1.66

Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. Health Technol Assess (2005) 1.65

The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth (2011) 1.62

Comparative effectiveness clinical trials in psychiatry: superiority, noninferiority, and the role of active comparators. J Clin Psychiatry (2011) 1.61

Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? J Dev Behav Pediatr (2010) 1.61

Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA (2012) 1.59

Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry (2010) 1.57

A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain (2009) 1.52

Effect of providing information about normal test results on patients' reassurance: randomised controlled trial. BMJ (2007) 1.49

A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci (2008) 1.47

How to use a noninferiority trial: users' guides to the medical literature. JAMA (2012) 1.46

Meta-analysis of the placebo response in antidepressant trials. J Affect Disord (2009) 1.40

Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med (2007) 1.39

Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation. Depress Anxiety (2004) 1.38

Acupuncture treatment in irritable bowel syndrome. Gut (2005) 1.37

Are drug and placebo effects in depression additive? Biol Psychiatry (2000) 1.35

Do "placebo responders" exist? Contemp Clin Trials (2008) 1.35

Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res (2005) 1.34

The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain (2002) 1.34

Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med (2011) 1.30

Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain (2009) 1.30

Behavioral conditioning of immunosuppression is possible in humans. FASEB J (2002) 1.29

Signal detection and placebo response in schizophrenia: parallels with depression. Psychopharmacol Bull (2010) 1.29

The persistence of the placebo response in antidepressant clinical trials. J Psychiatr Res (2007) 1.28

Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med (2006) 1.27

Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain (2006) 1.24

Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol (2007) 1.23

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints. Aliment Pharmacol Ther (2012) 1.22

The effects of suggestion and emotional arousal on pulmonary function in asthma: a review and a hypothesis regarding vagal mediation. Psychosom Med (1992) 1.22

Cultural variations in the placebo effect: ulcers, anxiety, and blood pressure. Med Anthropol Q (2000) 1.22

Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One (2012) 1.21

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Arch Gen Psychiatry (2005) 1.20

Dispositional optimism predicts placebo analgesia. J Pain (2010) 1.17

Step-wedge cluster-randomised community-based trials: an application to the study of the impact of community health insurance. Health Res Policy Syst (2008) 1.15

Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res (Hoboken) (2010) 1.14

Integrating predictive biomarkers and classifiers into oncology clinical development programmes. Nat Rev Drug Discov (2011) 1.14

The importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disability. Neurol Sci (2011) 1.09

Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci (1999) 1.08

Worries about modernity predict symptom complaints after environmental pesticide spraying. Psychosom Med (2005) 1.06

White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain (2012) 1.06

Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J Physiol (2009) 1.05

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One (2007) 4.92

Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry (2005) 4.41

Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (2013) 3.83

Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet (2010) 3.21

The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci (2006) 3.03

Psychological treatments for fibromyalgia: a meta-analysis. Pain (2010) 2.78

Placebo analgesia: psychological and neurobiological mechanisms. Pain (2013) 2.65

New insights into the placebo and nocebo responses. Neuron (2008) 2.64

Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron (2009) 2.55

The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet (2007) 2.35

Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br J Psychiatry (2013) 2.16

What is "normal" disability? An investigation of disability in the general population. Pain (2009) 2.11

Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res (2012) 1.90

Direct evidence for spinal cord involvement in placebo analgesia. Science (2009) 1.82

Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab (2006) 1.80

Is there a better term than "medically unexplained symptoms"? J Psychosom Res (2010) 1.77

Anterior insula integrates information about salience into perceptual decisions about pain. J Neurosci (2010) 1.72

Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev (2005) 1.70

Prestimulus functional connectivity determines pain perception in humans. Proc Natl Acad Sci U S A (2009) 1.61

Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol (2005) 1.59

The course of nonspecific chest pain in primary care: symptom persistence and health care usage. Arch Intern Med (2010) 1.57

Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 1.56

Somatoform disorders-new approaches to classification, conceptualization, and treatment. J Psychosom Res (2004) 1.53

Effect of providing information about normal test results on patients' reassurance: randomised controlled trial. BMJ (2007) 1.49

G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia. Brain Behav Immun (2008) 1.49

Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull (2007) 1.47

Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Med (2006) 1.44

Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback (2008) 1.42

Development and Validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12). Psychosom Med (2016) 1.42

Do we need a third mechanistic descriptor for chronic pain states? Pain (2016) 1.39

Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain Behav Immun (2006) 1.37

Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol (2005) 1.36

The epidemiology of the proposed DSM-5 hoarding disorder: exploration of the acquisition specifier, associated features, and distress. J Clin Psychiatry (2011) 1.32

Behavioral conditioning of immunosuppression is possible in humans. FASEB J (2002) 1.29

Decoding the perception of pain from fMRI using multivariate pattern analysis. Neuroimage (2012) 1.28

Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun (2007) 1.27

Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun (2005) 1.27

Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol (2006) 1.26

Psychometric properties and population-based norms of the Life Orientation Test Revised (LOT-R). Br J Health Psychol (2011) 1.25

G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol (2005) 1.24

Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res (2010) 1.24

Prefrontal cortex modulates placebo analgesia. Pain (2009) 1.21

Quantification of DeQi sensation by visual analog scales in healthy humans after immunostimulating acupuncture treatment. Am J Chin Med (2007) 1.20

How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires. J Psychosom Res (2013) 1.18

Lessons learned from placebo groups in antidepressant trials. Philos Trans R Soc Lond B Biol Sci (2011) 1.17

The placebo effect: advances from different methodological approaches. J Neurosci (2011) 1.13

Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology (2010) 1.12

Stigmatizing attitudes toward obesity in a representative population-based sample. Obesity (Silver Spring) (2008) 1.12

Attention modulates spinal cord responses to pain. Curr Biol (2012) 1.11

Treatment of internet addiction: a meta-analysis. Clin Psychol Rev (2013) 1.10

Emotion regulation and binge eating in children. Int J Eat Disord (2009) 1.10

What determines public support of obesity prevention? J Epidemiol Community Health (2007) 1.09

Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology (2004) 1.09

Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry (2013) 1.09

A classification of chronic pain for ICD-11. Pain (2015) 1.09

Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. Am J Physiol Gastrointest Liver Physiol (2007) 1.07

Loss of control eating and psychological maintenance in children: an ecological momentary assessment study. Behav Res Ther (2008) 1.07

The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneuroendocrinology (2008) 1.06

Worries about modernity predict symptom complaints after environmental pesticide spraying. Psychosom Med (2005) 1.06

White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain (2012) 1.06

Orgasm-induced prolactin secretion: feedback control of sexual drive? Neurosci Biobehav Rev (2002) 1.05

Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation (2004) 1.05

Treating pain with pain: supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation. Pain (2010) 1.05

The jumping to conclusions bias in delusions: specificity and changeability. J Abnorm Psychol (2010) 1.05

Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis (2008) 1.05

Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav Immun (2007) 1.02

Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol (2005) 1.01

Can antistigma campaigns be improved? A test of the impact of biogenetic vs psychosocial causal explanations on implicit and explicit attitudes to schizophrenia. Schizophr Bull (2007) 1.01

Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. J Consult Clin Psychol (2008) 1.01

Flexible cerebral connectivity patterns subserve contextual modulations of pain. Cereb Cortex (2010) 1.01

beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation (2006) 1.01

Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci (2012) 1.00

Can delusions be self-assessed? Concordance between self- and observer-rated delusions in schizophrenia. Psychiatry Res (2010) 0.99

Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol (2004) 0.99

Stimulation of β₂-adrenergic receptors inhibits calcineurin activity in CD4(+) T cells via PKA-AKAP interaction. Brain Behav Immun (2010) 0.97

Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom (2005) 0.97

G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. Gut (2007) 0.97

Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod (2006) 0.96

Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PLoS One (2011) 0.96

A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res (2003) 0.96

Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain (2012) 0.95

How effective are acceptance strategies? A meta-analytic review of experimental results. J Behav Ther Exp Psychiatry (2012) 0.95

Vestibular stimulation on a motion-simulator impacts on mood States. Front Psychol (2012) 0.95

Blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans. J Neurosci (2008) 0.95

Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol (2006) 0.94

GRK2 in sensory neurons regulates epinephrine-induced signalling and duration of mechanical hyperalgesia. Pain (2011) 0.94

Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain (2011) 0.94

Lifetime traumatic experiences and posttraumatic stress disorder in the German population: results of a representative population survey. J Nerv Ment Dis (2011) 0.94

Structural brain abnormalities in the frontostriatal system and cerebellum in pedophilia. J Psychiatr Res (2006) 0.93

Advancing psychotherapy and evidence-based psychological interventions. Int J Methods Psychiatr Res (2014) 0.93

Personality and psychopathology in children with and without loss of control over eating. Compr Psychiatry (2010) 0.93

Brain response to visual sexual stimuli in heterosexual and homosexual males. Hum Brain Mapp (2008) 0.93

Who Comes, Who Stays, Who Profits? Predicting refusal, dropout, success, and relapse in a short intervention for social phobia. Psychother Res (2005) 0.93

[Are migrants more susceptible to mental disorders?]. Psychiatr Prax (2008) 0.93

Behavioural conditioning as the mediator of placebo responses in the immune system. Philos Trans R Soc Lond B Biol Sci (2011) 0.93

Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs (2014) 0.93

Prolactin secretory rhythm in women: immediate and long-term alterations after sexual contact. Hum Reprod (2012) 0.92